Poll: What pipeline presbyopia treatment are you most looking forward to?

Poll

This poll is for optometrists and eyecare professionals, only. It will close on Friday, November 5, 2021.

What pipeline presbyopia treatment are you most looking forward to?

A. Orasis CSF-1
B. Allergan AGN-190584 drop
C. Eyenovia MicroLine drop
D. Presbyopia Therapies PRX-100
E. Ocuphire Pharma Nyxol
F. Visus Therapeutics Brimochol

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
AnnMarie Hipsley, DPT, PhD, at ASCRS 2025
Neda Shamie, MD; Selina McGee, OD, FAAO, Dipl ABO; and Jacob Lang, OD, FAAO; provided their insights during CIME 2025 on May 4.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Dr Jacob Lang at the 2025 Controversies in Modern Eye Care meeting
At ASCRS 2025, Alex Hacopian, MD, shares information from his presentation on next-gen presbyopia-correcting intraocular lenses.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Billy R. Hammond details the study, which explored how HEV-light filtering, specifically in the 380-440 nanometer range, impacts visual comfort for patients with presbyopia.
Kurt Moody, OD, FAAO, describes how to fit multifocal contact lenses in a way that patients love
Jacob R. Lang, OD, FAAO
The ins and outs of fitting multifocal contact lenses with Dr Jessica Crooker
© 2025 MJH Life Sciences

All rights reserved.